By exposing small amounts of blood to Ultraviolet light, the immune cells can become enhanced. Studies have shown that UVB IV Therapy can produce anti-inflammatory effects for auto-immune conditions. One study was a comparison review of two treatments for Psoriasis, UVB vs. Methotrexate. UVB IV therapy is non-toxic, not harmful and produced identical effects to Methotrexate without any toxicity. Methotrexate is a form of chemo therapy that is used in treatment of several auto-immune conditions.
We use this therapy for people with auto-immune diseases as well as cancer and infections. There is a beneficial increase in blood oxygen levels after the treatments and immune enhancement generally occurs after the 3-4th treatment and continues through the 12th session. We suggest a minimum of 1 treatment a week for 12 weeks. Some patients need an aggressive plan and benefit more from 2 per week for 6 weeks.